AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00- £345.57m
- £368.41m
- £55.20m
REG - Allergy Therapeutics - Half-Year Trading Update 2024
AnnouncementREG - Allergy Therapeutics - Notice of 2023 Annual General Meeting
AnnouncementREG - AIM Allergy Therapeutics - Restoration - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Publication of Annual Report and Accounts 2023
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - AIM Allergy Therapeutics - Suspension - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Amendment to existing Facility Agreement
AnnouncementREG - Allergy Therapeutics - Annual Report and Accounts Delayed
AnnouncementREG - Allergy Therapeutics - PDMR dealing and Total Voting Rights
AnnouncementREG - Allergy Therapeutics - G306 Phase III trial meets key endpoints
AnnouncementREG - Allergy Therapeutics - Update on funding
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - Allergy Therapeutics - G306 Grass Phase III trial meets primary endpoint
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Allergy Therapeutics - Director/PCA Dealing
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement